Despite several genetic studies revealing that CD226 was a susceptibility genetic factor for RA in different ethnic groups [11-18], neither inactivation of DNAM-1 nor a molecular targeted strategy using a neutralizing mAb against DNAM-1 prevented from CIA. Here, CD226 is linked to rheumatoid arthritis.